Search

Your search keyword '"Tommaso Grassi"' showing total 106 results

Search Constraints

Start Over You searched for: Author "Tommaso Grassi" Remove constraint Author: "Tommaso Grassi"
106 results on '"Tommaso Grassi"'

Search Results

1. An assessment of climate change impacts on oases in northern Africa

3. Outcome of patients with stage I immature teratoma after surveillance or adjuvant chemotherapy

5. Advanced low grade serous ovarian cancer: A retrospective analysis of surgical and chemotherapeutic management in two high volume oncological centers

6. Implementation of Chemistry in the Athena++ Code

7. Personalized tumor-specific DNA junctions to detect circulating tumor in patients with endometrial cancer

8. Measuring health literacy combining performance-based and self-assessed measures: the roles of age, educational level and financial resources in predicting health literacy skills. A cross-sectional study conducted in Florence (Italy)

13. Supplementary Figures 1-5 and Tables 1-3 from Signals from the Metastatic Niche Regulate Early and Advanced Ovarian Cancer Metastasis through miR-4454 Downregulation

14. Figure S10 from Genome-wide Copy-number Alterations in Circulating Tumor DNA as a Novel Biomarker for Patients with High-grade Serous Ovarian Cancer

15. Supplementary Table S9 from Genome-wide Copy-number Alterations in Circulating Tumor DNA as a Novel Biomarker for Patients with High-grade Serous Ovarian Cancer

16. Supplementary Results from Genome-wide Copy-number Alterations in Circulating Tumor DNA as a Novel Biomarker for Patients with High-grade Serous Ovarian Cancer

17. Data from Genome-wide Copy-number Alterations in Circulating Tumor DNA as a Novel Biomarker for Patients with High-grade Serous Ovarian Cancer

18. Supplementary Methods from Genome-wide Copy-number Alterations in Circulating Tumor DNA as a Novel Biomarker for Patients with High-grade Serous Ovarian Cancer

19. A comprehensive investigation of histotype-specific microRNA and their variants in Stage I epithelial ovarian cancers

20. Presence of liquid water during the evolution of exomoons orbiting ejected free-floating planets

27. 2022-RA-1052-ESGO Low-risk endometrial cancer and no adjuvant treatment: do isolated tumor cells (ITC) have an effect on recurrence? An international multi-institutional comparative study between ITC and node-negative in sentinel lymph node biopsy

28. Short‐term efficacy and safety of total skin electron beam therapy in mycosis fungoides: Systematic review and meta‐analysis

29. Binding Energy Evaluation Platform: A database of quantum chemical binding energy distributions for the astrochemical community

30. The shift from inpatient to outpatient hysterectomy for endometrial cancer in the United States: trends, enabling factors, cost, and safety

31. Genome-wide Copy-number Alterations in Circulating Tumor DNA as a Novel Biomarker for Patients with High-grade Serous Ovarian Cancer

32. A prospective multicenter international single-arm observational study on the oncological safety of the sentinel lymph node algorithm in stage I intermediate-risk endometrial cancer (SELECT, SEntinel Lymph node Endometrial Cancer Trial)

33. Modelling thermochemical processes in protoplanetary discs I: numerical methods

34. Combining positron emission tomography/computed tomography, radiomics, and sentinel lymph node mapping for nodal staging of endometrial cancer patients

35. Practice patterns and 90-day treatment-related morbidity in early-stage cervical cancer

36. Not all stage I and II endometrial cancers are created equal: Recurrence-free survival and cause-specific survival after observation or vaginal brachytherapy alone in all subgroups of early-stage high-intermediate and high-risk endometrial cancer

37. Targeted Mutational Analysis of Circulating Tumor DNA to Decipher Temporal Heterogeneity of High-Grade Serous Ovarian Cancer

38. Characteristics and patterns of care of endometrial cancer before and during COVID-19 pandemic

39. Presence of water on exomoons orbiting free-floating planets: a case study

40. Genes associated with bowel metastases in ovarian cancer

41. Oncologic and fertility impact of surgical approach for borderline ovarian tumours treated with fertility sparing surgery

42. Modelling H2 and its effects on star formation using a joint implementation of gadget -3 and KROME

43. Personalized tumor-specific DNA junctions to detect circulating tumor in patients with endometrial cancer

44. Astrochemical Modeling : Practical Aspects of Microphysics in Numerical Simulations

45. ASO Author Reflections: How Long will We Perform Lymphadenectomy in Endometrial Cancer Patients?

46. Not all high-intermediate risk endometrial cancers are created equal: recurrence-free survival and cause-specific survival after observation or vaginal brachytherapy in all possible subgroups of early-stage high-intermediate risk endometrial cancer

47. Regional and temporal heterogeneity of epithelial ovarian cancer tumor biopsies: implications for therapeutic strategies

48. Timing of surgery following SARS-CoV-2 infection: an international prospective cohort study

49. On the low ortho-to-para H2ratio in star-forming filaments

50. Early-stage clear cell ovarian cancer compared to high-grade histological subtypes: An outcome exploratory analysis in two oncology centers

Catalog

Books, media, physical & digital resources